Lung Cancer/X
Dec 3, 2024, 17:22
Actions to Boost Lung Cancer Research and Innovation
Giannis Mountzios, Consultant Medical Oncologist of the 2nd Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center, shared a recent article by M.-L. Meyer on X:
“A strategic position statement in Annals of Oncology on the main actions to boost lung cancer research and innovation:
- Pragmatic trials
- Ensure inclusivity and diversity
- NGS in resectable NSCLC
- Exploit resistance mechanism
- Focus on novel Tox”
Title: Lung cancer research and treatment: global perspectives and strategic calls to action
Authors: M.-L. Meyer, S. Peters, T.S. Mok, S. Lam, P.-C. Yang, C. Aggarwal, J. Brahmer, R. Dziadziuszko, E. Felip, A. Ferris, P.M. Forde, J. Gray, L. Gros, B. Halmos, R. Herbst, P.A. Jänne, B.E. Johnson, K. Kelly, N.B. Leighl, S. Liu and F.R. Hirsch
More posts featuring Giannis Mountzios.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 3, 2024, 17:22
Dec 3, 2024, 17:18
Dec 3, 2024, 16:31